Pilgrim Partners Asia’s Chemed CHE Stock Holding History

Pilgrim Partners Asia’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100	Closed	-$44.8K	–	125
2025 Q3	$44.8K	Buy	+100	New	+$45.3K	0.02%	103

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Pilgrim Partners Asia's CHE Position: Q4 2025 in Review

Pilgrim Partners Asia sold out of Chemed (CHE) in Q4 2025, closing a stake of 100 shares — an estimated $44.8K sold.

Pilgrim Partners Asia first reported a position in CHE in Q3 2025 and held it in 1 quarter. The position peaked at $44.8K in Q3 2025. 518 funds tracked by Wall St. Rank hold CHE as of Q4 2025.

Pilgrim Partners Asia reported no remaining Chemed position as of Q4 2025 after selling out during the quarter.
Pilgrim Partners Asia sold 100 Chemed shares in Q4 2025, an estimated $44.8K.
Pilgrim Partners Asia first reported a position in Chemed in Q3 2025 and held it in 1 quarter.
Pilgrim Partners Asia's Chemed position peaked at $44.8K in Q3 2025.
518 funds tracked by Wall St. Rank held Chemed as of Q4 2025.

Based on Pilgrim Partners Asia's 13F filing for Q4 2025, filed 3 Feb 2026.